Toxic neurofilamentous axonopathies and fast axonal transport. v. reduced bidirectional vesicle transport in cultured neurons by acrylamide and glycidamide
- C. H. Harris,
- A. K. Gulati,
- M. A. Friedman,
- D. W. Sickles(corresponding author)
- Augusta University,
- ,
- Pfizer
Abstract
Fast axonal transport deficiencies as mechanisms of action of aoylamide in producing axonal degeneration are under evaluation. The current study determines the effects of acry- lamide and several analogues on the number of vesicles moving within the neurite processes of cultured rat embryonic neurons. Acrylamide produced severe, concentration- dependent (0.25-1.0 mM) and time-dependent (0-60 min) reduction in the quantity of vesicles translocated in both the anterograde and retrograde directions. Clycidamide, a potential neurotoxic metabolite of acrylamide, produced a time-dependent but not a concentration-dependent (in the 0.25-1.0 mM range) reduction in bidirectional transport. Based on inhibition at 60 min, glycidamide was estimated to be 4 times more potent than acrylamide in altering transport. Propionamide, a C1,-C2saturated nonneurotoxic acrylamide analogue, had no effect on axonal transport. While a tendency for methylene bisacrylamide (MbACR) to reduce vesicle transport was noted, at the concentration used no statistically significant differences from control were observed. The data support the correlation between toxicant-induced fast anterograde and retrograde axonal transport reductions and axonal degeneration produced by acrylamide and its analogues.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 343-356 (14 pages)Journal (Volume, Issue Number)
Journal of Toxicology and Environmental Health (Volume 42, Issue 3)Publication milestones
- Published - 07/1994
Publication status
ISSN
0098-4108Publication IDs
- Scopus: 0028175589
- PubMed: 7517455
